{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:59:03Z","timestamp":1792155543911,"version":"4.4.0"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2025,9,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing (AST) publishes annual updates to the M100\n                      <jats:italic toggle=\"yes\">Performance Standards for Antimicrobial Susceptibility Testing<\/jats:italic>\n                      . This important document contains key information critical to the laboratory\u2019s performance of accurate and current AST. This minireview will highlight and provide supporting data for major changes in the M100 32nd and 33rd editions published in February 2022 and March 2023, respectively. New and revised breakpoints for gram-negative and gram-positive organisms are explained. Proper use of the restructured M100 Table 1 guidance for antimicrobial agents to be considered for testing and reporting is outlined. Reporting guidance for multidrug-resistant gram-negative bacilli is discussed. Other topics within this minireview include additional agents to test and report for direct blood disk diffusion of gram-negative bacilli and quality control range changes and troubleshooting. The minireview concludes with other issues under consideration by the AST Subcommittee.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/jcm.01623-23","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T13:13:04Z","timestamp":1754572384000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":110,"title":["Overview of changes in the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: M100 32nd and 33rd editions"],"prefix":"10.1128","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5837-270X","authenticated-orcid":true,"given":"Audrey N.","family":"Schuetz","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science","place":["Rochester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2012-0141","authenticated-orcid":false,"given":"Andrea","family":"Ferrell","sequence":"additional","affiliation":[{"name":"R&D, BD Life Sciences","place":["Sparks, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Hindler","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017dm4063","id-type":"ROR","asserted-by":"publisher"}],"name":"Public Health Laboratories, Los Angeles County Department of Public Health","place":["Los Angeles, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6568-156X","authenticated-orcid":true,"given":"Romney","family":"Humphries","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05dq2gs74","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center","place":["Nashville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6167-198X","authenticated-orcid":false,"given":"April M.","family":"Bobenchik","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04p491231","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Pathology and Laboratory Medicine, Penn State Hershey Medical Center","place":["Hershey, USA"]},{"name":"Deparment of Pathology, Division of Clinical Pathology, Penn State College of Medicine","place":["Hershey, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","volume-title":"Performance standards for antimicrobial susceptibility testing, M100","author":"CLSI","year":"2022","unstructured":"CLSI. 2022. Performance standards for antimicrobial susceptibility testing, M100. 32nd ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"32"},{"key":"e_1_3_1_3_2","volume-title":"Performance standards for antimicrobial susceptibility testing, M100","author":"CLSI","year":"2023","unstructured":"CLSI. 2023. Performance standards for antimicrobial susceptibility testing, M100. 33rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"33"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.786"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/520991"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.650"},{"key":"e_1_3_1_7_2","volume-title":"Development of in vitro susceptibility test methods, breakpoints, and quality control parameters, M23","author":"CLSI","year":"2023","unstructured":"CLSI. 2023. Development of in vitro susceptibility test methods, breakpoints, and quality control parameters, M23. 6th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"6"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/9781420017137.001"},{"key":"e_1_3_1_9_2","unstructured":"USCAST. 2019. USCAST report 002 version 1.3. Aminoglycoside in vitro susceptibility test interpretive criteria evaluations. Available from: https:\/\/www.uscast.org\/documents. Retrieved 9 Jun 2025."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac688"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad012"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.12163"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1479"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2351"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1711"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01617-22"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00243-22"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00951-20"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.01600-22"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2021.10.021"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00074-22"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad428"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab092"},{"key":"e_1_3_1_24_2","volume-title":"Performance standards for antimicrobial susceptibility testing, M100","author":"CLSI","year":"2021","unstructured":"CLSI. 2021. Performance standards for antimicrobial susceptibility testing, M100. 31st ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"31"},{"key":"e_1_3_1_25_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M07","author":"CLSI","year":"2018","unstructured":"CLSI. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, M07. 11th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"11"},{"key":"e_1_3_1_26_2","volume-title":"Performance standards for antimicrobial disk susceptibility tests, M02","author":"CLSI","year":"2018","unstructured":"CLSI. 2018. Performance standards for antimicrobial disk susceptibility tests, M02. 13th ed. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"13"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00203-19"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00106-25"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.01623-23","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.01623-23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T13:01:19Z","timestamp":1757509279000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.01623-23"}},"subtitle":[],"editor":[{"given":"Alexander J.","family":"McAdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,10]]}},"alternative-id":["10.1128\/jcm.01623-23"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01623-23","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"2025-08-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01623-23"}}